Literature DB >> 28964535

Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man.

Melissa A Levoska1, Jeffrey I Cohen2, Irini Manoli3, Chyi-Chia Richard Lee4, Steven S T Ching5, Jessica Shand6, Deborah Tamura7, Kenneth H Kraemer7, John J DiGiovanna8.   

Abstract

KEY TEACHING POINTS. Published by Elsevier Inc.

Entities:  

Keywords:  EBV-associated lymphoproliferative disorders; Epstein-Barr virus; hydroa vacciniforme; photodermatosis; photosensitivity

Mesh：

Year:  2017        PMID： 28964535      PMCID： PMC5815928          DOI： 10.1016/j.jaad.2017.08.005

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  44 in total

1.  A clinical study on severe hydroa vacciniforme.

Authors:  H Gu; B Chang; H Qian; G Li
Journal:  Chin Med J (Engl)       Date:  1996-08       Impact factor: 2.628

2.  Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma.

Authors:  M Magaña; P Sangüeza; J Gil-Beristain; S Sánchez-Sosa; A Salgado; G Ramón; O P Sangüeza
Journal:  J Am Acad Dermatol       Date:  1998-04       Impact factor: 11.527

3.  Hydroa vacciniforme present for 48 years with cytotoxic CD4+ T-cell infiltration and Epstein-Barr virus infection.

Authors:  J-L Xie; G-Y Chen; Y Jin; X-D Zheng; X-J Wei; Y-Y Zheng; S-H Zhang; Y-N Zhang; X-J Zhang; X-G Zhou
Journal:  Br J Dermatol       Date:  2011-11-03       Impact factor: 9.302

4.  Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.

Authors:  L Verneuil; S Gouarin; F Comoz; F Agbalika; C Creveuil; M Varna; A Vabret; A Janin; D Leroy
Journal:  Br J Dermatol       Date:  2010-03-29       Impact factor: 9.302

5.  Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection.

Authors:  M Helminen; N Lahdenpohja; M Hurme
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

6.  [Hydroa vacciniforme: dietary fish oil].

Authors:  A B Modeste; N Cordel; X Balguerie; D Leroy; P Lauret; P Joly
Journal:  Ann Dermatol Venereol       Date:  2001-03       Impact factor: 0.777

Review 7.  Hypersensitivity to mosquito bites as the primary clinical manifestation of a juvenile type of Epstein-Barr virus-associated natural killer cell leukemia/lymphoma.

Authors:  Y Tokura; S Ishihara; S Tagawa; N Seo; K Ohshima; M Takigawa
Journal:  J Am Acad Dermatol       Date:  2001-10       Impact factor: 11.527

8.  Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.

Authors:  Anja Pahlow Mose; Niels Fisker; Ole Clemmensen; Anette Bygum
Journal:  BMJ Case Rep       Date:  2014-11-24

Review 9.  NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management.

Authors:  S E Straus; J I Cohen; G Tosato; J Meier
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

10.  Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010.

Authors:  Jennifer Beam Dowd; Tia Palermo; Jennifer Brite; Thomas W McDade; Allison Aiello
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240
View more
  1 in total

1.  Hydroa vacciniforme-like lymphoproliferative disorder: an EBV disease with a low risk of systemic illness in whites.

Authors:  Jeffrey I Cohen; Irini Manoli; Kennichi Dowdell; Tammy A Krogmann; Deborah Tamura; Pierce Radecki; Wei Bu; Siu-Ping Turk; Kelly Liepshutz; Ronald L Hornung; Hiva Fassihi; Robert P Sarkany; Lori L Bonnycastle; Peter S Chines; Amy J Swift; Timothy G Myers; Melissa A Levoska; John J DiGiovanna; Francis S Collins; Kenneth H Kraemer; Stefania Pittaluga; Elaine S Jaffe
Journal:  Blood       Date:  2019-05-07       Impact factor: 25.476
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.